<table id="_RefID2DB3CD6E930C47C18E0902F62AC2F65C" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption> Table 4. Effect of cinacalcet co-administration on other drugs </caption>
<col width="24%"></col>
<col width="24%"></col>
<col width="24%"></col>
<col width="27%"></col>
<tbody>
<tr>
<td align="center" rowspan="2" stylecode="Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Cinacalcet dosing regimen</content>
</paragraph>
</td>
<td align="center" colspan="3" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Co-administered drug</content>
</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Lrule Botrule ">
<paragraph>
<content stylecode="bold">Name and Dose</content>
</paragraph>
</td>
<td align="center" stylecode="Lrule Botrule ">
<paragraph>
<content stylecode="bold">Mean change in AUC<sub>(0-inf)</sub>
</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">Mean change in C<sub>max</sub>
</content>
</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Botrule ">
<paragraph>30 mg twice daily for 8 days </paragraph>
</td>
<td align="center">
<paragraph>25 mg warfarin<footnote id="_RefIDF9D0DA97CA1E405CAF54181774E6A4B6">No significant change in prothrombin time.</footnote> tablet<sup>†</sup>
</paragraph>
</td>
<td align="center">
<paragraph>↑1 % for R-warfarin</paragraph>
<paragraph>↓1% S-warfarin</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>↓10 % for R-warfarin </paragraph>
<paragraph>↓12 % for S-warfarin </paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Botrule ">
<paragraph>90 mg daily for 7 days to CYP2D6 extensive metabolizers </paragraph>
</td>
<td align="center">
<paragraph>50 mg desipramine<footnote id="_RefID5F08CC4213634F0E815644C9B6B2232D">Single dose on day 5.</footnote> </paragraph>
</td>
<td align="center">
<paragraph>↑264% </paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>↑75%</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Botrule ">
<paragraph>90 mg daily for 5 days </paragraph>
</td>
<td align="center">
<paragraph>2 mg midazolam<footnoteref idref="_RefID5F08CC4213634F0E815644C9B6B2232D"></footnoteref> </paragraph>
</td>
<td align="center">
<paragraph>↑5%</paragraph>
</td>
<td align="center" stylecode="Rrule Lrule Botrule ">
<paragraph>↓5%</paragraph>
</td>
</tr>
<tr>
<td align="center" stylecode="Botrule Lrule ">
<paragraph>25 or 100 mg single dose to CYP2D6 extensive metabolizers </paragraph>
</td>
<td align="center" stylecode="Botrule Lrule ">
<paragraph>50 mg amitriptyline single dose</paragraph>
</td>
<td align="center" stylecode="Botrule Lrule ">
<paragraph>↑21-22% for amitriptyline</paragraph>
<paragraph>↑17-23% for nortriptyline<footnote id="_RefID4A38449118B54990B60087DD8B4FF72D">Nortriptyline is an active metabolite of amitriptyline.</footnote>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule ">
<paragraph>↑13-21% for amitriptyline</paragraph>
<paragraph>↑11-15% for nortriptyline<footnoteref idref="_RefID4A38449118B54990B60087DD8B4FF72D"></footnoteref>
</paragraph>
</td>
</tr>
</tbody>
</table>